The Clorox Company (CLX)

NYSE: CLX · USD

$86.8

+0.73 (+0.8%)· Recorded snapshot

Английский по умолчаниюRU

Показываем английский источник, пока идёт перевод

Этот отчёт ещё не переведён. Обновите страницу через несколько минут, когда очередь переводов его обработает.

StockMarketAgent Research · Analyzed 2026-09-20

Our latest published analysis: CLX rated Buy

The Clorox Company's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$105 / share

Potential value

$186 / share

Upside to FV

+26.1%

from $86.8

Moat

6.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$10.0B
Revenue (ttm)	6.7B
Net income (ttm)	587M
EPS (ttm)	$4.81
Shares out	120.9M
P/E (trailing)	18.1x
P/E (forward)	14.2x
Dividend	$5.00 (5.75%)
Volume	1,933,519
Beta	0.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.7B
Net income (ttm): 587M
EPS (ttm): $4.81
P/E (trailing): 18.1x
P/E (forward): 14.2x
Market cap: $10.0B

Item	P1	P2	P3	P4	P5	Trend
Period	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30	Trend
Revenue	$7.11B	$7.39B	$7.09B	$7.10B	$6.72B	-1.4%
Gross profit	$2.55B	$2.91B	$3.05B	$3.21B	$2.84B	+2.8%
Operating income	$713.0M	$328.0M	$488.0M	$1.17B	$921.0M	+6.6%
Net income	$462.0M	$149.0M	$280.0M	$810.0M	$587.0M	+6.2%
EPS (diluted)	$3.73	$1.20	$2.25	$6.52	$5.54	+10.4%
EBITDA	$937.0M	$564.0M	$723.0M	$1.39B	$921.0M	-0.4%
R&D	$132.0M	$138.0M	$126.0M	$121.0M	$116.0M	-3.2%
SG&A	$954.0M	$1.18B	$1.17B	$1.12B	$317.0M	-24.1%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
BA	The Boeing Company	132.2B	18.0x	1.4x	-0.8%	+8.6%	-25.2%	Продавать
BMY	Bristol-Myers Squibb Company	123.6B	13.3x	2.5x	21.7%	+2.1%	+45.8%	Продавать
CHTR	Charter Communications, Inc.	17.2B	2.7x	0.3x	8.5%	+1.7%	-57.3%	Активно покупать
ADM	Archer-Daniels-Midland Company	37.3B	21.2x	0.5x	5.0%	+1.8%	+28.5%	Сокращать
BF.B	Brown-Forman Corporation Class B	12.7B	17.9x	3.3x	14.3%	+1.6%	+0.4%	Покупать
CAG	Conagra Brands, Inc.	6.6B	—	0.6x	9.2%	+0.2%	-18.9%	Активно покупать

Base and Bull scenarios

Base40%

Price target

$104.80

+26.1% from spot

Modal turnaround path where retail distribution breadth recovers while promotional reinvestment supports Fair value of $104.80.

Order fulfillment normalizes to recover distribution footprint
Operating margins normalize in line with defensive peer averages
Operating cash generation sustains debt service and dividend requirements

Bull10%

Price target

$185.52

+123.2% from spot

Turnaround execution outpaces expectations as consumer loyalty drives retail shelf replenishment and margin expansion toward Potential value of $185.52.

Retail distribution expands faster than expected across grocery channels
Operating margins expand beyond historical baselines through fixed-cost absorption
Brand equity preserves pricing power against competitor promotions

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($104.80). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	0.5%	0.5%	1.0%	1.5%	2.0%
5.9%	$107	$107	$107	$107	$107
6.9%	$106	$106	$106	$106	$106
7.9%	$105	$105	$105	$105	$105
8.9%	$104	$104	$104	$104	$104
9.9%	$102	$102	$102	$102	$102

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E14.2

P25 n/aP50 n/aP75 n/a

Trailing P/E17.3

P25 n/aP50 n/aP75 n/a

ROE163.8

P25 n/aP50 n/aP75 n/a

ROIC14.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CLX indicators

Market & fundamental data

Available fields

287

Groups with data

Currency

USD

Showing 287 of 287 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000021076
Company name	The Clorox Company
Country	United States
Country code	US
CUSIP number	189054109
Earnings date	2026-11-02
Earnings time	amc
Employees	9,200
Employees change	1,600
Employees growth	21.05%
Enterprise value	$16B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	June
Founded	1913
In index	SP500
Industry	Household & Personal Products
Is primary listing	Yes
Is SPAC	No
ISIN number	US1890541097
Last 10-K release date	2026-08-07
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split date	1999-08-24
Last stock split type	Forward
Market cap	$10.5B
Market cap category	Large-Cap
Next earnings date	2026-11-02
Options	Yes
Price	$86.84
Price currency	USD
Sector	Consumer Staples
SIC code	2842
Stock price date	2026-10-28
Symbol	CLX
U.S. state	California
Website	https://www.thecloroxcompany.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	15.68x
Average P/E ratio (10Y)	48.48x
Average P/E ratio (3Y)	63.84x
Average P/E ratio (5Y)	72.46x
Earnings yield	5.54%
EV/Earnings	27.16x
EV/EBIT	17.94x
EV/EBITDA	13.99x
EV/FCF	39.37x
EV/Sales	2.37x
FCF / EV yield	2.54%
FCF yield	3.86%
Forward EV/Sales	2.09x
Forward P/E	15.24x
Forward P/S	1.37x
Graham number	8.97479
Graham upside	-89.65%
Industry forward P/E	20.39x
Industry P/E	23.28x
Lynch fair value	$24.05
Lynch upside	-72.27%
P/(FCF - SBC) ratio	29.38x
P/(OCF - SBC) ratio	18.6x
P/B ratio	117.38x
P/E ratio	18.05x
P/FCF ratio	25.9x
P/OCF ratio	17.14x
P/S ratio	1.56x
PEG ratio	2.83x
Price/EBITDA ratio	9.2x
Sector forward P/E	21.3x
Sector P/E	28.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	13.23%
EBITDA margin	16.96%
Effective tax rate	24.02%
FCF margin	6.03%
Gross margin	42.32%
Operating margin	13.23%
Pretax margin	11.77%
Profit margin	8.74%
Profit per employee	$63,804
Profitable quarters	9
Profitable years	34
Revenue per employee	$730,435
ROA	8.32%
ROA (5Y)	9.35%
ROCE	17.71%
ROE	163.76%
ROE (5Y)	99.89%
ROIC	14.86%
ROIC (5Y)	19.4%
SBC / revenue	0.71%
Tax / revenue	2.83%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-26.23%
EPS growth (Q)	-50.1%
EPS growth (QoQ)	-12.96%
EPS growth 10Y	-0.23%
EPS growth 3Y	58.85%
EPS growth 5Y	-2.93%
EPS growth years	0
FCF growth	-46.78%
FCF growth (Q)	11.42%
FCF growth 3Y	-24.2%
FCF growth 5Y	-15.59%
Gross profit growth	-11.35%
Gross profit growth (Q)	-12.99%
Gross profit growth 3Y	-0.7%
Gross profit growth 5Y	-2.41%
Net income growth	-27.53%
Net income growth (Q)	-50.9%
Net income growth (QoQ)	-12.83%
Net income growth 3Y	57.94%
Net income growth 5Y	-3.73%
Net income growth years	0
OCF growth	-37.62%
OCF growth (Q)	12.25%
OCF growth 10Y	-2.37%
OCF growth 3Y	-19.15%
OCF growth 5Y	-13.67%
Operating income growth	-24.98%
Operating income growth (Q)	-39.81%
Operating income growth 3Y	3.07%
Operating income growth 5Y	-6.32%
Revenue growth	-5.41%
Revenue growth (Q)	-2.01%
Revenue growth (QoQ)	16.65%
Revenue growth 10Y	1.55%
Revenue growth 3Y	-3.11%
Revenue growth 5Y	-1.75%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-207M
Depreciation and amortization	$251M
EBIT	$889M
EBITDA	$1.1B
EPS	$4.81
FCF per share	$3.35
Financing cash flow	$1.7B
Free cash flow	$405M
Free cash flow minus SBC	$357M
Gross profit	$2.8B
Income taxes	$190M
Investing cash flow	$-2.3B
Net borrowing	$2.6B
Net cash flow	$-23M
Net income	$587M
Operating cash flow minus SBC	$564M
Operating income	$889M
Revenue	$6.7B
Stock-based compensation	$48M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.23
Book value per share	$0.74
Debt / EBITDA	4.4
Debt / equity	22.21
Debt / FCF	13.82
Goodwill	$1.9B
Interest coverage	6.84
Long-term assets	$6B
Long-term liabilities	$4.8B
Net cash (debt)	$-5.5B
Net cash / market cap	-52%
Net debt / EBITDA	4.79
Net debt / equity	21.65
Net debt / FCF	13.47
Piotroski F-Score	4
Property, plant and equipment	$2B
Shareholders' equity	$252M
Tangible book value	$-3.5B
Tangible book value per share	$-28.53
Total assets	$7.8B
Total cash	$143M
Total debt	$5.6B
Total liabilities	$7.5B
WACC	5.45%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.01
Current assets	$1.8B
Current liabilities	$2.8B
Current ratio	0.66
Inventory turnover	5.96
Net working capital	$97M
Quick ratio	0.34
Working capital	$-949M
Working capital turnover	-10.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.73%
Dividend growth	1.22%
Dividend growth (10Y)	4.72%
Dividend growth (3Y)	1.52%
Dividend growth (5Y)	1.87%
Dividend growth years	49
Dividend payment date	2026-11-13
Dividend payment years	56
Dividend payout frequency	Quarterly
Dividend per share	$5.00
Dividend yield	5.75%
Ex-dividend date	2026-10-28
FCF payout ratio	149.3%
Last dividend	$1.25
Payout ratio	103.95%
Shareholder yield	7.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-26.3%
10Y return CAGR	0.04%
10Y total return	0.38%
150-day SMA	$94.76
15Y price change	28.93%
15Y return CAGR	4.87%
15Y total return	103.93%
1D price change	0.85%
1M price change	3.75%
1M total return	5.25%
1W price change	-0.58%
1W total return	0.86%
1Y price change	-24.73%
1Y return CAGR	-20.91%
1Y total return	-20.9%
20-day SMA	$84.85
200-day SMA	$99.99
20Y price change	35.25%
20Y return CAGR	4.67%
20Y total return	149.26%
3M price change	-10.75%
3M total return	-8.39%
3Y price change	-26.28%
3Y return CAGR	-5.99%
3Y total return	-16.93%
50-day SMA	$89.34
50-day SMA vs 200-day SMA	50under200
52-week high	$128.90
52-week high date	2026-02-26
52-week low	$79.12
52-week low date	2026-10-01
5Y price change	-45.52%
5Y return CAGR	-8.14%
5Y total return	-34.58%
6M price change	-10.06%
6M total return	-7.68%
All-time high	$239.87
All-time high date	2020-08-05
All-time low	$0.69
All-time low date	1974-12-23
Average true range (ATR)	$2.28
Average volume	2.4M
Beta (1Y)	0.56
Beta (2Y)	0.33
Beta (5Y)	0.57
Change from 52-week high	-32.63%
Change from 52-week low	9.76%
Change from all-time high	-63.76%
Change from all-time low	12,545.82%
Change from open	1.42%
Day's gap	-0.57%
Dollar volume	$167.9M
High price	$87.28
Low price	$85.36
Monthly RSI	36.75
Open price	$85.62
Position in 52-week range	77.08%
Premarket change	-2.52%
Premarket close	$87.36
Premarket price	$85.16
Premarket volume	16K
Previous close	$86.11
Price vs 150-day SMA	-8.25%
Price vs 20-day SMA	2.46%
Price vs 200-day SMA	-13.05%
Price vs 50-day SMA	-2.69%
Relative volume	0.81
RSI	51.51
Sharpe ratio	-0.7
Sharpe ratio (3Y)	-0.3
Sharpe ratio (5Y)	-0.33
Sortino ratio	-0.76
Sortino ratio (3Y)	-0.2
Sortino ratio (5Y)	-0.25
Volume	1.9M
Weekly RSI	41.04
YTD price change	-13.78%
YTD total return	-9.39%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	120.5M
Float percentage	99.64%
Shares change (QoQ)	0.02%
Shares change (YoY)	-1.73%
Shares held by insiders	0.28%
Shares held by institutions	87.17%
Shares outstanding	120.9M
Short % of float	9.61%
Short % of shares	9.58%
Short ratio	3.2 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	194

Deeper analysis on CLX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this CLX report

What is the latest published CLX stock rating?

The Clorox Company is shown with Buy in the latest published report, analyzed 2026-09-20. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CLX analysis?

The full latest published report, analyzed 2026-09-20, lives at /stocks/CLX/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for CLX?

The latest published report analyzed 2026-09-20 gives CLX a fair value of USD 105 and a potential value of USD 186. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the CLX page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-09-20). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

BuyCLX · Fair value $105+26.1%

Read full analysis →

The Clorox Company (CLX)

Our latest published analysis: CLX rated Buy

Price

Financial snapshot

Fair-value bridge

Latest news · CLX

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All CLX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CLX

Frequently asked questions

История рейтингов

Category	Score	Reading
Valuation	7.5
Management	7.5
Balance Sheet	1.5
Profitability	7.0
Revenue Growth	2.5
Risk Assessment	3.5
Competitive Moat	6.5
Earnings Quality	4.5
Capital Efficiency	7.5